The emerging roles of microvesicles in liver diseases

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 6, 2014, Pages 350-361

  Lemoinne, Sara ^a   Thabut, Dominique ^a   Housset, Chantal ^a   Moreau, Richard ^a   Valla, Dominique ^a   Boulanger, Chantal M ^b   Rautou, Pierre Emmanuel ^b  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; COLLAGENASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PHOSPHATIDYLSERINE; RIBONUCLEOPROTEIN; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; UNTRANSLATED RNA;

ACUTE LIVER FAILURE; ALCOHOL CONSUMPTION; ANGIOGENESIS; ASCITES; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEMBRANE PERMEABILITY; CELL VACUOLE; CORONARY ARTERY DISEASE; DNA FRAGMENTATION; FIBROGENESIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; METABOLIC SYNDROME X; MICROVESICLE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA DEGRADATION; SHEAR STRESS; VASOCONSTRICTION; VASODILATATION; ZYMOGRAPHY;

BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; CARCINOMA, HEPATOCELLULAR; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MICROCIRCULATION; MICROVESSELS;

EID: 84901976256     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.7     Document Type: Review

References (117)

1. Witwer, K. W. et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles 2, 20360 (2013).
2. van der Pol, E., Boing, A. N., Harrison, P., Sturk, A. &Nieuwland, R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64, 676-705 (2012).
3. Connor, D. E., Exner, T., Ma, D. D. &Joseph, J. E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb. Haemost. 103, 1044-1052 (2010).
4. Mause, S. F. &Weber, C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 107, 1047-1057 (2010).
5. Rautou, P. E. &Mackman, N. Deletion of microvesicles from the circulation. Circulation 125, 1601-1604 (2012).
6. Bernimoulin, M. et al. Differential stimulation of monocytic cells results in distinct populations of microparticles. J. Thromb. Haemost. 7, 1019-1028 (2009).
7. Leroyer, A. S. et al. CD40 ligand microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J. Am. Coll. Cardiol. 52, 1302-1311 (2008).
8. Berckmans, R. J., Sturk, A., van Tienen, L. M., Schaap, M. C. &Nieuwland, R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 117, 3172-3180 (2011).
9. Rood, I. M. et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int. 78, 810-816 (2010).
10. Witek, R. P. et al. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology 136, 320-330 (2009).
11. Boilard, E. et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327, 580-583 (2010).
12. Chahed, S. et al. Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation. Diabetes 59, 694-701 (2010).
13. Franz, C. et al. Procoagulant tissue factor-exposing vesicles in human seminal fluid. J. Reprod. Immunol. 98, 45-51 (2013).
14. Leroyer, A. S. et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 119, 2808-2817 (2009).
15. Baron, M. et al. PPAR? activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH. Atherosclerosis 218, 69-76 (2011).
16. Amabile, N., Rautou, P. E., Tedgui, A. &Boulanger, C. M. Microparticles: key protagonists in cardiovascular disorders. Semin. Thromb. Hemost. 36, 907-916 (2010).
17. Rautou, P. E. &Mackman, N. Microvesicles as risk markers for venous thrombosis. Expert Rev. Hematol. 6, 91-101 (2013).
18. Zahra, S., Anderson, J. A., Stirling, D. &Ludlam, C. A. Microparticles, malignancy and thrombosis. Br. J. Haematol. 152, 688-700 (2011).
19. Fusegawa, H. et al. Platelet activation in patients with chronic hepatitis C. Tokai J. Exp. Clin. Med. 27, 101-106 (2002). (Pubitemid 36460571)
20. Brodsky, S. V. et al. Dynamics of circulating microparticles in liver transplant patients. J. Gastrointestin. Liver Dis. 17, 261-268 (2008).
21. Sayed, D., Amin, N. F. &Galal, G. M. Monocyte-platelet aggregates and platelet micro-particles in patients with post-hepatitic liver cirrhosis. Thromb. Res. 125, e228-e233 (2010).
22. Kornek, M., Popov, Y., Libermann, T. A., Afdhal, N. H. &Schuppan, D. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 53, 230-242 (2011).
23. Ogasawara, F. et al. Platelet activation in patients with alcoholic liver disease. Tokai J. Exp. Clin. Med. 30, 41-48 (2005). (Pubitemid 40628372)
24. Rautou, P. E. et al. Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology 143, 166-176 (2012).
25. Kornek, M. et al. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 143, 448-458 (2012).
26. Esch, J. S. et al. Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation. Platelets 21, 348-359 (2010).
27. Agarwal, B. et al. Evaluation of coagulation abnormalities in acute liver failure. J. Hepatol. 57, 780-786 (2012).
28. Agarwal, B. et al. Hemostasis in patients with acute kidney injury secondary to acute liver failure. Kidney Int. 84, 158-163 (2013).
29. Stravitz, R. T. et al. Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology 58, 304-313 (2013).
30. Schmelzle, M. et al. Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. Transplantation 95, 63-69 (2013).
31. Chen, Y., Davis-Gorman, G., Watson, R. R. &McDonagh, P. F. Platelet CD62p expression and microparticle in murine acquired immune deficiency syndrome and chronic ethanol consumption. Alcohol 38, 25-30 (2003). (Pubitemid 36204360)
32. Meckes, D. G. Jr &Raab-Traub, N. Microvesicles and viral infection. J. Virol. 85, 12844-12854 (2011).
33. Diamant, M. et al. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106, 2442-2447 (2002). (Pubitemid 35278799)
34. Esposito, K. et al. Endothelial microparticles correlate with endothelial dysfunction in obese women. J. Clin. Endocrinol. Metab. 91, 3676-3679 (2006). (Pubitemid 44402155)
35. Ferreira, A. C. et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 110, 3599-3603 (2004). (Pubitemid 39612577)
36. Navasiolava, N. M. et al. Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers. Am. J. Physiol. Heart Circ. Physiol. 299, H248-H256 (2010).
37. Guicciardi, M. E. &Gores, G. J. Apoptosis as a mechanism for liver disease progression. Semin. Liver Dis. 30, 402-410 (2010).
38. Violi, F. et al. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J. Hepatol. 55, 1415-1427 (2011).
39. Miyoshi, H. et al. Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. Gastroenterology 110, 1897-1904 (1996). (Pubitemid 26169227)
40. Cazzaniga, M. et al. Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistive index. Liver Int. 28, 1396-1401 (2008).
41. Tazi, K. A. et al. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 122, 1869-1877 (2002). (Pubitemid 34651431)
42. Rasaratnam, B., Kaye, D., Jennings, G., Dudley, F. &Chin-Dusting, J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann. Intern. Med. 139, 186-193 (2003).
43. Nomura, S., Nakamura, T., Cone, J., Tandon, N. N. &Kambayashi, J. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry 40, 173-181 (2000). (Pubitemid 30441519)
44. Abid Hussein, M. N. et al. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J. Thromb. Haemost. 3, 888-896 (2005). (Pubitemid 41632816)
45. Essayagh, S. et al. Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by 3-integrin antagonists. Thromb. Haemost. 94, 853-858 (2005). (Pubitemid 41489249)
46. Szotowski, B. et al. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation-and cytokine-induced endothelial cells. Cardiovasc. Res. 73, 806-812 (2007). (Pubitemid 46227358)
47. Liu, M. L., Reilly, M. P., Casasanto, P., McKenzie, S. E. &Williams, K. J. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler. Thromb. Vasc. Biol. 27, 430-435 (2007). (Pubitemid 46143061)
48. Li, D. et al. TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b. Oncoimmunology 1, 687-693 (2012).
49. Povero, D. et al. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require vanin-1 for uptake by endothelial cells. Sci. Signal. 6, ra88 (2013).
50. Al Faraj, A. et al. Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice. Radiology 263, 169-178 (2012).
51. Willekens, F. L. et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 105, 2141-2145 (2005). (Pubitemid 40731805)
52. Gomez, F., Ruiz, P. &Schreiber, A. D. Impaired function of macrophage Fc receptors and bacterial infection in alcoholic cirrhosis. N. Engl. J. Med. 331, 1122-1128 (1994). (Pubitemid 24321217)
53. Chen, L., Pan, D. D., Zhou, J. &Jiang, Y. Z. Protective effect of selenium-enriched Lactobacillus on CCl4-induced liver injury in mice and its possible mechanisms. World J. Gastroenterol. 11, 5795-5800 (2005). (Pubitemid 41662828)
54. Rimola, A. et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4, 53-58 (1984). (Pubitemid 14185424)
55. Tanimoto, A. et al. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 222, 661-666 (2002). (Pubitemid 34215210)
56. Dasgupta, S. K., Le, A., Chavakis, T., Rumbaut, R. E. &Thiagarajan, P. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 125, 1664-1672 (2012).
57. Distler, J. H. et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc. Natl Acad. Sci. USA 102, 2892-2897 (2005). (Pubitemid 40299887)
58. Taraboletti, G. et al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 160, 673-680 (2002). (Pubitemid 34160345)
59. Gasser, O. et al. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp. Cell. Res. 285, 243-257 (2003). (Pubitemid 36432112)
60. Szabo, G. &Bala, S. MicroRNAs in liver disease. Nat. Rev. Gastroenterol. Hepatol. 10, 542-552 (2013).
61. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
62. Diehl, P. et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 93, 633-644 (2012).
63. Cantaluppi, V. et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82, 412-427 (2012).
64. Thabut, D. &Shah, V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J. Hepatol. 53, 976-980 (2010).
65. Mause, S. F. et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 122, 495-506 (2010).
66. Benameur, T., Soleti, R., Porro, C., Andriantsitohaina, R. &Martinez, M. C. Microparticles carrying Sonic hedgehog favor neovascularization through the activation of nitric oxide pathway in mice. PLoS ONE 5, e12688 (2010).
67. Deregibus, M. C. et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110, 2440-2448 (2007). (Pubitemid 47523165)
68. Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172 (2008).
69. Thabut, D. et al. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology 46, 1893-1906 (2007).
70. Aram, G., Potter, J. J., Liu, X., Torbenson, M. S. &Mezey, E. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration. Hepatology 47, 2051-2058 (2008). (Pubitemid 351945571)
71. Nieuwland, R. et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95, 930-935 (2000). (Pubitemid 30063043)
72. Owens, A. P. 3rd &Mackman, N. Microparticles in hemostasis and thrombosis. Circ. Res. 108, 1284-1297 (2011).
73. Valla, D. C. Thrombosis and anticoagulation in liver disease. Hepatology 47, 1384-1393 (2008). (Pubitemid 351547924)
74. Teoh, N. C. et al. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology 133, 632-646 (2007). (Pubitemid 47187352)
75. Garcia-Pagan, J. C., Gracia-Sancho, J. &Bosch, J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J. Hepatol. 57, 458-461 (2012).
76. Lemoinne, S. et al. Portal myofibroblasts promote liver angiogenesis through the release of microparticles and interaction with cholangiocytes. Hepatology 56, 304A-305A (2012).
77. Schwartz, D. et al. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J. Clin. Invest. 100, 439-448 (1997). (Pubitemid 27349092)
78. Mostefai, H. A. et al. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am. J. Respir. Crit. Care Med. 178, 1148-1155 (2008).
79. Melgar-Lesmes, P. et al. Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats. Gut 58, 285-292 (2009).
80. Densmore, J. C. et al. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock 26, 464-471 (2006). (Pubitemid 44632275)
81. Perez-Casal, M. et al. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica 94, 387-394 (2009).
82. Tripodi, A. &Mannucci, P. M. The coagulopathy of chronic liver disease. N. Engl. J. Med. 365, 147-156 (2011).
83. Press, J. Z. et al. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration. Int. J. Gynecol. Cancer 22, 546-552 (2012).
84. Ginestra, A., Miceli, D., Dolo, V., Romano, F. M. &Vittorelli, M. L. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res. 19, 3439-3445 (1999). (Pubitemid 30000200)
85. Choi, D. S. et al. Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 11, 2745-2751 (2011).
86. Cejudo-Martin, P. et al. Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients. Hepatology 36, 1172-1179 (2002). (Pubitemid 35253433)
87. Jimenez, W. et al. Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients. Hepatology 30, 670-676 (1999). (Pubitemid 29409411)
88. Morales-Ruiz, M. et al. Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway. J. Hepatol. 43, 85-91 (2005). (Pubitemid 40805277)
89. Wright, G. &Jalan, R. Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology 46, 291-294 (2007). (Pubitemid 47344761)
90. Wright, G. et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 45, 1517-1526 (2007). (Pubitemid 46918336)
91. Jayakumar, A. R., Tong, X. Y., Ospel, J. &Norenberg, M. D. Role of cerebral endothelial cells in the astrocyte swelling and brain edema associated with acute hepatic encephalopathy. Neuroscience 218, 305-316 (2012).
92. Rodriguez-Roisin, R. &Krowka, M. J. Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N. Engl. J. Med. 358, 2378-2387 (2008).
93. Amabile, N. et al. Cellular microparticles in the pathogenesis of pulmonary hypertension. Eur. Respir. J. 42, 272-279 (2013).
94. Camus, S. M. et al. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood 120, 5050-5058 (2012).
95. Tripodi, A. et al. An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137, 2105-2111 (2009).
96. Tripodi, A., Anstee, Q. M., Sogaard, K. K., Primignani, M. &Valla, D. C. Hypercoagulability in cirrhosis: causes and consequences. J. Thromb. Haemost. 9, 1713-1723 (2011).
97. Tripodi, A., Primignani, M., Lemma, L., Chantarangkul, V. &Mannucci, P. M. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. J. Hepatol. 59, 265-270 (2013).
98. Wiest, R. &Garcia-Tsao, G. Bacterial translocation (BT) in cirrhosis. Hepatology 41, 422-433 (2005). (Pubitemid 40289486)
99. Rautou, P.-E., Vion, A.-C., Luyendyk, J. P. &Mackman, N. Microparticle tissue factor activity is increased in patients with cirrhosis. Hepatology (in press).
100. Stravitz, R. T. et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J. Hepatol. 56, 129-136 (2012).
101. Ganey, P. E. et al. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology 46, 1177-1186 (2007). (Pubitemid 350144782)
102. Zafrani, L. et al. Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release. Am. J. Respir. Crit. Care Med. 185, 744-755 (2012).
103. Thaler, J. et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J. Thromb. Haemost. 10, 1363-1370 (2012).
104. Rak, J. Microparticles in cancer. Semin. Thromb. Hemost. 36, 888-906 (2010).
105. Al-Nedawi, K., Meehan, B., Kerbel, R. S., Allison, A. C. &Rak, J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl Acad. Sci. USA 106, 3794-3799 (2009).
106. Al-Nedawi, K. et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619-624 (2008). (Pubitemid 351627382)
107. Jaiswal, R. et al. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J. 26, 420-429 (2012).
108. Shedden, K., Xie, X. T., Chandaroy, P., Chang, Y. T. &Rosania, G. R. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 63, 4331-4337 (2003). (Pubitemid 36950999)
109. Sidhu, S. S., Mengistab, A. T., Tauscher, A. N., LaVail, J. &Basbaum, C. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23, 956-963 (2004). (Pubitemid 38250941)
110. Ma, J. et al. Innate immune cell-derived microparticles facilitate hepatocarcinoma metastasis by transferring integrin (M)(2) to tumor cells. J. Immunol. 191, 3453-3461 (2013).
111. Fonsato, V. et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30, 1985-1998 (2012).
112. Villa, E. et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 143, 1253-1260 (2012).
113. Hu, J. et al. Plasma microRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation 95, 991-999 (2013).
114. Lacroix, R. et al. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J. Thromb. Haemost. 11, 1190-1193 (2013).
115. European Association of National Metrology Institutes (EURA-MET). Metrological characterisation of micro-vesicles from body fluids as non-invasive diagnostic biomarkers [online], http://www.metves.eu (2014).
116. European Cooperation in Science and Technology (COST). European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD) [online], http://www.cost.eu/domains-actions/bmbs/Actions/BM1202 (2012).
117. Herrera, M. B. et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J. Cell. Mol. Med. 14, 1605-1618 (2010).